New York, March 31, 2023 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Hyperphosphatemia Treatment Global Market Report 2023" - https ...

DUBAI, United Arab Emirates, Jan. 10, 2023 (GLOBE NEWSWIRE) -- Future Market Insights estimates that the Hyperphosphatemia Market will experience a rapid expansion between the years 2023 and 2033. By ...

Editor’s note: This is an automatically generated transcript. Please notify [email protected] if there are concerns regarding accuracy of the transcription The kidneys, in addition to removing toxins, ...

LONDON--(BUSINESS WIRE)--Technavio has announced their latest drug pipeline analysis report on hyperphosphatemia. The report includes a comprehensive research on the pipeline molecules under ...

Please provide your email address to receive an email when new articles are posted on . “So, what can we do beyond binders?” he asked during the presentation. One method is to increase the frequency ...

Tenapanor, a novel agent that has been submitted to the US Food and Drug Administration (FDA) for approval for the treatment of hyperphosphatemia in patients undergoing dialysis, moved a step closer ...

Nov. 4, 2002 — Lanthanum carbonate (Fosrenol) is safe and effective for the treatment of hemodialysis patients with hyperphosphatemia, according to two presentations on Nov. 2 at the American Society ...

Future Market Insights projects that between 2023 and 2033, the hyperphosphatemia market would grow rapidly. The global market for pharmaceuticals treating hyperphosphatemia is predicted to expand at ...

Investigators ruled out hyperphosphatemia and SHPT as confounders in each other's association with CKD outcomes. Secondary hyperparathyroidism (SHPT) is associated with progression of chronic kidney ...

Diabetes, COPD Raise Post-Kidney Transplant Readmission Rates High phosphate levels are associated with 3.3-fold increased odds of 28-day in-hospital mortality. Hyperphosphatemia predicts an increased ...

Unicycive Therapeutics, Inc. UNCY, a clinical-stage company, issued a letter to its shareholders providing corporate updates and key upcoming milestones for the company in 2024. Following the issuance ...